[{"address1": "14/15 Conduit Street", "city": "London", "zip": "W1S 2XJ", "country": "United Kingdom", "phone": "44 20 7495 2379", "website": "https://www.tizianalifesciences.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Tiziana Life Sciences Ltd, a biotechnology company, engages in the development of transformative therapies for neurodegenerative and lung diseases in the United States. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for use in the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases. It is also developing TZLS-501, a fully human mAb targeting the IL-6 receptor for use in the treatment of inflammatory and oncology indications. Tiziana Life Sciences Ltd was incorporated in 1998 and is headquartered in London, the United Kingdom.", "fullTimeEmployees": 9, "companyOfficers": [{"maxAge": 1, "name": "Mr. Gabriele Marco Antonio Cerrone M.B.A.", "age": 53, "title": "Founder & Executive Chairman", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 1853000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ivor R. Elrifi Ph.D.", "title": "CEO & Executive Director", "fiscalYear": 2024, "totalPay": 131000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Keeren  Shah", "age": 49, "title": "COO & CFO", "yearBorn": 1976, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Napoleone  Ferrara M.D.", "age": 68, "title": "Member of Scientific Advisory Board", "yearBorn": 1957, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.49, "open": 1.5, "dayLow": 1.49, "dayHigh": 1.605, "regularMarketPreviousClose": 1.49, "regularMarketOpen": 1.5, "regularMarketDayLow": 1.49, "regularMarketDayHigh": 1.605, "payoutRatio": 0.0, "beta": 0.229, "forwardPE": -8.024532, "volume": 149629, "regularMarketVolume": 149629, "averageVolume": 312750, "averageVolume10days": 210720, "averageDailyVolume10Day": 210720, "bid": 1.41, "ask": 1.48, "bidSize": 2, "askSize": 1, "marketCap": 192331840, "fiftyTwoWeekLow": 0.63, "fiftyTwoWeekHigh": 2.6, "allTimeHigh": 12.17, "allTimeLow": 0.41, "fiftyDayAverage": 1.7166, "twoHundredDayAverage": 1.6424, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 182974416, "profitMargins": 0.0, "floatShares": 63425878, "sharesOutstanding": 120207401, "sharesShort": 1565099, "sharesShortPriorMonth": 1435362, "sharesShortPreviousMonthDate": 1763078400, "dateShortInterest": 1765756800, "sharesPercentSharesOut": 0.012999999, "heldPercentInsiders": 0.46562, "heldPercentInstitutions": 0.03421, "shortRatio": 3.81, "shortPercentOfFloat": 0.02, "impliedSharesOutstanding": 120207402, "bookValue": 0.077, "priceToBook": 20.77922, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -12841000, "trailingEps": -0.12, "forwardEps": -0.19938856, "lastSplitFactor": "2499:1000", "lastSplitDate": 1596153600, "enterpriseToEbitda": -9.91, "52WeekChange": 1.1621621, "SandP52WeekChange": 0.14778805, "quoteType": "EQUITY", "currentPrice": 1.6, "targetHighPrice": 7.9862137, "targetLowPrice": 7.9862137, "targetMeanPrice": 7.9862137, "targetMedianPrice": 7.9862137, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 1, "totalCash": 7251000, "totalCashPerShare": 0.061, "ebitda": -18464000, "totalDebt": 107000, "quickRatio": 1.649, "currentRatio": 1.719, "debtToEquity": 1.163, "returnOnAssets": -0.83782, "returnOnEquity": -2.32311, "freeCashflow": -3856625, "operatingCashflow": -8749000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "TLSA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Tiziana Life Sciences Ltd", "longName": "Tiziana Life Sciences Ltd", "corporateActions": [], "postMarketTime": 1767391190, "regularMarketTime": 1767387600, "exchange": "NCM", "messageBoardId": "finmb_261234197", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 7.38255, "regularMarketPrice": 1.6, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1542724200000, "postMarketChangePercent": 0.0, "postMarketPrice": 1.6, "postMarketChange": 0.0, "regularMarketChange": 0.11, "regularMarketDayRange": "1.49 - 1.605", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 312750, "marketState": "CLOSED", "fiftyTwoWeekLowChange": 0.97, "fiftyTwoWeekLowChangePercent": 1.5396826, "fiftyTwoWeekRange": "0.63 - 2.6", "fiftyTwoWeekHighChange": -0.9999999, "fiftyTwoWeekHighChangePercent": -0.38461536, "fiftyTwoWeekChangePercent": 116.21621, "earningsTimestampStart": 1750708800, "earningsTimestampEnd": 1752004800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.12, "epsForward": -0.19938856, "epsCurrentYear": -0.133, "priceEpsCurrentYear": -12.030075, "fiftyDayAverageChange": -0.11659992, "fiftyDayAverageChangePercent": -0.067924924, "twoHundredDayAverageChange": -0.042400002, "twoHundredDayAverageChangePercent": -0.02581588, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Tiziana Life Sciences PLC", "nameChangeDate": "2026-01-02", "averageAnalystRating": "1.0 - Strong Buy", "cryptoTradeable": false, "displayName": "Tiziana Life Sciences", "trailingPegRatio": null, "__fetch_time": "2026-01-03"}]